• SENSEX 73,033.78
    1,109.10 (+1.54%)
  • BANKNIFTY 55,481.05
    563.05 (+1.03%)
  • Infosys
    1,065.05 1,727.85(%)
  • Power Fin.Corpn.
    342.95 486.45(%)
  • Adani Ports
    1,775.95 1,891.80(%)
  • Kotak Mah. Bank
    437.50 345.40(%)
  • HCL Technologies
    1,323.95 1,770.00(%)
  • NSE
    1,768.00 1,878.00(%)
  • TCS
    2,267.00 3,336.70(%)
  • Max Healthcare
    843.00 843.00(%)
  • Max Financial
    1,340.45 1,891.35(%)
  • One 97
    1,714.00 1,856.50(%)
  • Caliber Mining
    654.80 654.80(%)
  • Pine Labs
    171.40 283.70(%)
  • Shringar House
    317.75 317.75(%)
  • Netweb Technol.
    5,075.00 5,810.00(%)
  • Schaeffler India
    3,570.00 3,519.00(%)
  • Reliance Industries
    1,168.00 1,611.20(%)
  • Sona BLW Precis.
    805.05 843.90(%)
  • Axis Bank
    1,274.65 1,418.30(%)
  • Sedemac Mechatro
    3,106.00 1,415.00(%)
  • Hitachi Energy
    29,581.50 16,104.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Asston Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 94417.0
  • ISIN : INE0SJX01015
92.90 -2 (-1.95%)
  • As on 13 Oct 2026 (EOD)

  • Today’s Low

    90.25

  • Today’s High

    97.00

  • Open

    97.00

  • Perv Close

    94.75

  • 52W Low

    60.00

  • 52W High

    126.10

Key Indicators

  • P/E(TTM)

    25.95

  • Mar.Cap (₹Cr.)

    101.47

  • Div & Yield %

    0.00

  • Book Value(₹)

    60.96

  • Debt-Equity Ratio

    -1.95

  • AGM Date

    13-Oct-2026

  • EPS

    3.58

  • P/E Ratio

    25.95

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    101.47

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    10.92

  • BV (₹)

    61.00

  • Sales( ₹ in Cr.)

    25.47

  • NP (in Cr.)

    3.91

  • NP Var(%)

    3.0

  • Div%

    0.0

  • CPS (₹)

    3.90

  • EPS (₹)

    3.60

  • Traded Value (₹ in Lakhs)

    101.47

  • 52 Week High

    126.10

  • 52 Week Low

    60.00

  • Price BSE

    93.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    101.47

  • P/C Ratio

    24.00

  • P/E Ratio

    26.00

  • Price Vs.BV

    3.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar
INCOME :            
Sales Turnover 25.47 25.04 16.03 6.54 9.60 -
Excise Duty 0.00 0.00 0.00 0.00 0.00 -
Net Sales 25.47 25.04 16.03 6.54 9.60 -
Other Income 6.12 0.57 0.25 0.65 0.96 -
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 -
Total Income 31.59 25.61 16.28 7.19 10.56 -
EXPENDITURE :            
Raw Materials 17.41 14.14 9.75 2.68 6.70 -
Power and Fuel Cost 0.17 0.14 0.01 0.00 0.00 -
Employee Cost 1.62 1.06 0.19 0.23 0.26 -
Other Manufacturing Expenses 0.55 0.21 0.12 0.67 0.98 -
Selling and Administration Expenses 4.99 3.17 2.13 1.42 2.00 -
Miscellaneous Expenses 1.29 0.87 0.01 0.02 0.01 -
Employee Benefit Expenses 1.62 1.06 0.19 0.23 0.26 -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 -
Total Expenses 26.03 19.60 12.20 5.02 9.95 -
Operating Profit 5.55 6.01 4.07 2.17 0.60 -
Interest 0.63 0.95 0.76 0.72 0.43 -
Gross Profit 4.92 5.06 3.31 1.45 0.17 -
Depreciation 0.32 0.04 0.06 0.04 0.01 -
Profit Before Tax 4.60 5.02 3.25 1.41 0.16 -
Current Tax 0.62 1.22 0.81 0.34 0.03 -
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 -
Deferred Tax 0.11 -0.06 0.01 0.02 0.02 -
Reported Net Profit 3.87 3.85 2.43 1.06 0.11 -
Extraordinary Items -0.05 0.07 0.00 0.00 0.00 -
Adjusted Net Profit 3.92 3.78 2.43 1.06 0.11 -
Adjustment below Net Profit 0.00 -2.53 0.00 0.00 0.00 -
P & L Balance brought forward 4.76 3.44 1.01 0.23 0.12 -
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 -
Appropriations 0.00 0.00 0.00 0.00 0.00 -
P & L Balance carried down 8.63 4.76 3.44 1.29 0.23 -
Dividend 0.00 0.00 0.00 0.00 0.00 -
Preference Dividend 0.00 0.00 0.00 0.00 0.00 -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 -
Earnings Per Share-Unit Curr 4.54 6.14 31.01 15.09 1.58 -
Earnings Per Share(Adj)-Unit Curr 4.54 - - - - -
Book Value 45.65 17.60 91.63 28.37 13.28 -
Book Value(Adj)-Unit Curr 45.65 - - - - -

Shareholding Pattern

  • Promoter Group

    39.48%

  • Public Share Holding

    60.52%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,312,480 39.48 4,312,480 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,312,480 39.48 4,312,480 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 927,258 8.49 927,258 18
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 138,678 1.27 138,678 11
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 99,293 0.91 99,293 40
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,908,089 35.78 3,908,089 40
Individuals holding nominal share capital up to Rs. 1 lakh 1,536,993 14.07 1,536,993 561
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6,610,311 60.52 6,610,311 670
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,922,791 100.00 10,922,791 673

Company Background

Asston Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs

  • Asston Pharmaceuticals Ltd
  • BSE Code : 94417.0
  • ISIN : INE0SJX01015

  • Incorporation Year

    2019

  • Registered Office

    4th Flr Office No.A-431 Balaji
    Bhavan Plot No.42A Sec-11 CBD, Mumbai,
    Maharashtra-400614

  • Telephone

    +91 22 4973 1411/+91 22 4973 1419

  • FAX

  • Chairman

  • Managing Director

    Ashish Narayan Sakalkar

  • Company Secretary

    Vandana Mishra

  • Auditor

    Doshi Doshi & Co/Panchal S K & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Maashitla Securities Pvt Ltd
    451 Krishna Apra Bus,
    Netaji Subhash Place,Pitampura
    Mumbai - New Delhi-110034

Asston Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Asston Pharmaceu 92.90 31.58 25.47 26.24 16.71
Abbott India 25,689.35 7,217.19 6,929.05 33.81 43.78
Astrazeneca Phar 5,887.00 2,304.07 2,275.58 86.76 27.86
Glaxosmi. Pharma 2,534.00 3,932.76 3,790.20 40.48 58.17
Novartis India 1,988.60 393.10 354.33 50.22 15.94
Cipla 1,330.00 20,102.60 18,979.95 34.95 13.88
Bliss GVS Pharma 671.15 773.53 729.81 62.37 12.51
Fermenta Biotec. 520.80 474.15 450.25 24.31 18.77
Amrutanjan Healt 508.65 520.13 502.55 27.24 24.16
Guj. Themis Bio. 371.60 168.25 165.82 99.36 18.05
Ambalal Sarabhai 38.69 19.52 3.94 71.65 6.77